# Endocannabinoid System: Cannabis, Pregnancy & Cytokines > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-use-during-pregnancy-maternal-cytokines-impact/ > **Published:** 2026-03-03T21:44:09-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T12:01:12-04:00 > **Clinical Summary:** Explore how cannabis use during pregnancy affects maternal cytokines and immune function, highlighting clinical concerns for gestational cannabis exposure. --- #### Clinical Takeaway [Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) during pregnancy is associated with measurable suppression of circulating maternal immune signaling proteins called cytokines, based on urine-verified exposure data. Because the immune system plays a critical role in supporting a healthy pregnancy, these findings raise important clinical concerns about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) during gestation. Pregnant patients should be counseled that cannabis is not considered safe during pregnancy, and no trimester of use has been established as risk-free. ### #25 Cannabis Use During Pregnancy Is Associated with the Suppression of Circulating Maternal Cytokines. **Citation:** Alshaarawy Omayma et al. *Cannabis Use During Pregnancy Is Associated with the Suppression of Circulating Maternal Cytokines.* Cannabis and [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/). 2026. PMID: 41104491. **Study type:** Journal Article  |  **Topic area:** Pediatrics  |  **CED Score:** 10 Design: 0 Journal: 1 N: 2 Recency: 3 Pop: 3 Human: 1 Risk: 0 Why This Matters Prenatal cannabis use is increasingly common yet remains understudied regarding its immunological consequences, which this research addresses by demonstrating THC-associated suppression of circulating maternal cytokines, a finding with potential implications for maternal-fetal immune tolerance and infection susceptibility during pregnancy. Altered maternal immune cytokine profiles could affect placental function, [fetal development](https://cedclinic.com/prenatal-cannabinoid-exposure-reproductive-health-insights/), and postpartum infection risk, making this immunological mechanism clinically relevant for informed counseling and risk stratification of pregnant patients using cannabis. These findings establish a biological pathway through which prenatal cannabis exposure may influence pregnancy outcomes, warranting further investigation into dose-response relationships and long-term developmental consequences. **Abstract:** INTRODUCTION: The prevalence of prenatal cannabis use has nearly doubled in the United States. Cannabinoid 2 receptors are predominately expressed in cells of the human immune system, and delta-9 tetrahydrocannabinol (THC), the primary active component of cannabis, has been shown to suppress immune responses. Despite these findings, there is very little evidence on the impact of cannabis use on maternal immune system. Here, we evaluate the association between urine-verified cannabis use and the levels of T helper cytokines in the maternal circulation. METHODS: This was an ancillary study of a prospective cohort of pregnant women who participated in the Michigan Archive for Research on Child Health study. Pregnant women (age ≥18 years) were recruited from 22 prenatal clinics in Michigan and matched on age, race, and tobacco smoking (n = 144). The urinary metabolite of delta-9 THC, 11-nor-9-carboxy-delta-9-THC (THC-COOH), was used to define cannabis use status. A bead-based assay was used for the simultaneous detection of maternal cytokines associated with cannabis use and pregnancy outcomes in previous studies. RESULTS: Repeated-measures linear mixed models indicated that urine-verified cannabis use was associated with the suppression of maternal pro-inflammatory cytokines including interferon gamma (β = -0.5; 95% confidence interval [CI] = -0.8, -0.1) and interleukin (IL)-12 (β = -0.3; 95% CI = -0.6, -0.05), as well as the anti-inflammatory IL-4 (β = -0.7; 95% CI = -1.3, -0.2) and IL-10 (β = -0.4; 95% CI = -0.7, -0.03). Similar results were observed when heavy cannabis use was defined using the top tertile of urinary THC-COOH at each trimester. CONCLUSIONS: Urine-verified cannabis use was associated with the suppression of pro- and anti-inflammatory T helper cytokines in a cohort of pregnant women, suggesting that cannabis use can lead to modest dysregulation of the maternal immune system. Additional studies are needed to investigate the role of maternal immune resp Clinical Perspective This study adds important mechanistic data suggesting that prenatal cannabis use may alter maternal immune function through suppression of circulating cytokines, a finding consistent with known cannabinoid receptor distribution in immune cells. However, several significant caveats warrant careful interpretation: the cross-sectional design prevents us from establishing causation or determining whether cytokine suppression is clinically harmful or beneficial in pregnancy, the study does not clarify whether observed immune changes translate to measurable adverse fetal or neonatal outcomes, and we lack data on cannabis potency, frequency, duration of use, or trimester-specific exposure, all of which could substantially affect immune response. Additionally, confounding variables such as maternal infection status, stress, nutrition, and concurrent substance use are potential alternate explanations for immune alterations. Pending prospective studies with clinical outcome measures, practitioners should continue counseling pregnant patients that cannabis use in pregnancy carries unknown risks to [fetal development](https://cedclinic.com/prenatal-cannabinoid-exposure-reproductive-health-insights/) and that current evidence supports abstinence, while acknowledging that mechanistic studies like this one help us [Full Article](https://doi.org/10.1177/25785125251388764)  |  [PubMed](https://pubmed.ncbi.nlm.nih.gov/41104491/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Endocannabinoid System & Maternal Cytokines: Clinical Research](https://cedclinic.com/maternal-immune-suppression-cannabis-pregnancy/) Delve deeper into [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) on how the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) influences maternal cytokines during pregnancy. [Read More](https://cedclinic.com/maternal-immune-suppression-cannabis-pregnancy/) [Endocannabinoid System: Cannabis & Maternal Cytokines](https://cedclinic.com/cannabis-use-during-pregnancy-immune-effects/) Explore detailed findings on cannabis effects on maternal cytokines and immune responses in pregnancy. [Explore Article](https://cedclinic.com/cannabis-use-during-pregnancy-immune-effects/) [Endocannabinoid System Effects: Cannabis in Pregnancy Study](https://cedclinic.com/maternal-cannabis-use-pregnancy-risks-research/) Review a comprehensive study examining cannabis use and its effects on the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) during pregnancy. [Learn More](https://cedclinic.com/maternal-cannabis-use-pregnancy-risks-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Endocannabinoid%20System%3A%20Cannabis%2C%20Pregnancy%20%26%20Cytokines&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-use-during-pregnancy-maternal-cytokines-impact%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-use-during-pregnancy-maternal-cytokines-impact%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Endocannabinoid%20System%3A%20Cannabis%2C%20Pregnancy%20%26%20Cytokines%20https%3A%2F%2Fcedclinic.com%2Fcannabis-use-during-pregnancy-maternal-cytokines-impact%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).